$LFST
LifeStance Health Group, Inc.

2024 Q2 Form 10-Q Financial Statement

#000095017024056989 Filed on May 09, 2024

View on sec.gov

Income Statement

Concept 2024 Q2 2024 Q1 2023 Q1
Revenue $312.3M $300.4M $252.6M
YoY Change 20.32% 18.94% 24.37%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $95.15M $88.93M $84.63M
YoY Change -6.58% 5.09% -18.13%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $10.13M $10.02M $8.896M
YoY Change 8.29% 12.65% 55.33%
% of Gross Profit
Operating Expenses $328.3M $317.2M $286.7M
YoY Change 6.59% 10.65% 6.99%
Operating Profit -$15.95M -$16.77M -$34.09M
YoY Change -67.06% -50.81% -47.43%
Interest Expense $5.823M $5.903M $5.092M
YoY Change 13.75% 15.93% 47.98%
% of Operating Profit
Other Income/Expense, Net -$6.674M -$3.962M -$4.186M
YoY Change 85.03% -5.35% 0.79%
Pretax Income -$22.62M -$20.73M -$38.28M
YoY Change -56.51% -45.83% -44.53%
Income Tax $656.0K $363.0K -$4.037M
% Of Pretax Income
Net Earnings -$23.28M -$21.10M -$34.24M
YoY Change -48.82% -38.39% -45.06%
Net Earnings / Revenue -7.45% -7.02% -13.56%
Basic Earnings Per Share
Diluted Earnings Per Share -$0.06 -$0.06 -$0.09
COMMON SHARES
Basic Shares Outstanding 382.3M 380.7M 376.4M
Diluted Shares Outstanding 379.4M 376.3M 360.9K

Balance Sheet

Concept 2024 Q2 2024 Q1 2023 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $86.97M $49.45M $68.29M
YoY Change 9.25% -27.59% -40.09%
Cash & Equivalents $86.97M $49.45M $68.29M
Short-Term Investments
Other Short-Term Assets $23.56M $18.73M $25.83M
YoY Change -35.42% -27.5% -52.44%
Inventory
Prepaid Expenses
Receivables $167.2M $175.9M $118.4M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $277.7M $244.1M $212.5M
YoY Change 16.76% 14.87% -19.29%
LONG-TERM ASSETS
Property, Plant & Equipment $175.9M $182.4M $193.5M
YoY Change -8.91% -5.73% 13.21%
Goodwill $1.293B $1.293B $1.294B
YoY Change -0.01% -0.02% 5.23%
Intangibles $200.1M $208.5M $254.0M
YoY Change -17.94% -17.89% -12.78%
Long-Term Investments
YoY Change
Other Assets $12.04M $12.05M $8.772M
YoY Change 7.33% 37.38% 138.43%
Total Long-Term Assets $1.842B $1.862B $1.946B
YoY Change -4.73% -4.31% 14.81%
TOTAL ASSETS
Total Short-Term Assets $277.7M $244.1M $212.5M
Total Long-Term Assets $1.842B $1.862B $1.946B
Total Assets $2.119B $2.106B $2.159B
YoY Change -2.38% -2.42% 10.22%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $9.973M $11.94M $7.709M
YoY Change 23.98% 54.86% -49.07%
Accrued Expenses $210.3M $187.4M $157.3M
YoY Change 32.29% 19.12% 65.6%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $2.925M $2.925M $2.345M
YoY Change 12.72% 24.73% 77.25%
Total Short-Term Liabilities $227.7M $207.5M $181.1M
YoY Change 25.88% 14.53% 44.22%
LONG-TERM LIABILITIES
Long-Term Debt $279.5M $279.9M $224.8M
YoY Change 12.36% 24.52% 26.71%
Other Long-Term Liabilities $571.0K $760.0K $2.059M
YoY Change -77.69% -63.09% -96.42%
Total Long-Term Liabilities $461.7M $469.9M $472.3M
YoY Change -6.77% -0.52% 62.71%
TOTAL LIABILITIES
Total Short-Term Liabilities $227.7M $207.5M $181.1M
Total Long-Term Liabilities $461.7M $469.9M $472.3M
Total Liabilities $689.3M $677.3M $653.4M
YoY Change 1.96% 3.66% 57.13%
SHAREHOLDERS EQUITY
Retained Earnings -$805.2M -$781.9M -$608.8M
YoY Change 23.07% 28.43% 45.17%
Common Stock $2.233B $2.208B $2.112B
YoY Change 4.08% 4.55% 7.65%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $1.430B $1.429B $1.505B
YoY Change
Total Liabilities & Shareholders Equity $2.119B $2.106B $2.159B
YoY Change -2.38% -2.42% 10.22%

Cashflow Statement

Concept 2024 Q2 2024 Q1 2023 Q1
OPERATING ACTIVITIES
Net Income -$23.28M -$21.10M -$34.24M
YoY Change -48.82% -38.39% -45.06%
Depreciation, Depletion And Amortization $10.13M $10.02M $8.896M
YoY Change 8.29% 12.65% 55.33%
Cash From Operating Activities $44.06M -$21.84M -$7.890M
YoY Change -10252.07% 176.78% -338.51%
INVESTING ACTIVITIES
Capital Expenditures $5.110M $5.104M $7.729M
YoY Change -55.88% -33.96% -72.31%
Acquisitions $0.00 $19.82M
YoY Change -100.0% -13.62%
Other Investing Activities $0.00 $0.00 -$19.82M
YoY Change -100.0% -13.62%
Cash From Investing Activities -$5.110M -$5.104M -$27.55M
YoY Change -55.88% -81.47% -45.83%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net $731.0K $586.0K
YoY Change 24.74% 77.04%
Cash From Financing Activities -1.432M -2.431M -4.888M
YoY Change -106.14% -50.27% -136.19%
NET CHANGE
Cash From Operating Activities 44.06M -21.84M -7.890M
Cash From Investing Activities -5.110M -5.104M -27.55M
Cash From Financing Activities -1.432M -2.431M -4.888M
Net Change In Cash 37.52M -29.37M -40.33M
YoY Change 231.69% -27.16% 18.47%
FREE CASH FLOW
Cash From Operating Activities $44.06M -$21.84M -$7.890M
Capital Expenditures $5.110M $5.104M $7.729M
Free Cash Flow $38.95M -$26.94M -$15.62M
YoY Change -424.18% 72.5% -36.51%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2024Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001845257
CY2024Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2024Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2024Q1 dei Amendment Flag
AmendmentFlag
false
CY2023Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2024Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2024Q1 us-gaap Derivative Asset Statement Of Financial Position Extensible Enumeration
DerivativeAssetStatementOfFinancialPositionExtensibleEnumeration
http://fasb.org/us-gaap/2023#OtherAssetsNoncurrent
CY2024Q1 dei Document Type
DocumentType
10-Q
CY2024Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2024Q1 dei Document Period End Date
DocumentPeriodEndDate
2024-03-31
CY2024Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
CY2024Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2024Q1 dei Entity File Number
EntityFileNumber
001-40478
CY2024Q1 dei Entity Registrant Name
EntityRegistrantName
LifeStance Health Group, Inc.
CY2024Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2024Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
86-1832801
CY2024Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
4800 N. Scottsdale Road
CY2024Q1 dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 2500
CY2024Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
Scottsdale
CY2024Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
AZ
CY2024Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
85251
CY2024Q1 dei City Area Code
CityAreaCode
602
CY2024Q1 dei Local Phone Number
LocalPhoneNumber
767-2100
CY2024Q1 dei Security12b Title
Security12bTitle
Common Stock, par value $0.01 per share
CY2024Q1 dei Trading Symbol
TradingSymbol
LFST
CY2024Q1 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2024Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2024Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2024Q1 dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2024Q1 dei Entity Small Business
EntitySmallBusiness
false
CY2024Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2024Q1 dei Entity Shell Company
EntityShellCompany
false
CY2024Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
382287766
CY2024Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
49451000
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
78824000
CY2024Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
175937000
CY2023Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
125405000
CY2024Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
18729000
CY2023Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
21502000
CY2024Q1 us-gaap Assets Current
AssetsCurrent
244117000
CY2023Q4 us-gaap Assets Current
AssetsCurrent
225731000
CY2024Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
182428000
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
188222000
CY2023Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2024Q1 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2023Q4 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2024Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
165845000
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
170703000
CY2024Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
208529000
CY2023Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
221072000
CY2024Q1 us-gaap Goodwill
Goodwill
1293346000
CY2023Q4 us-gaap Goodwill
Goodwill
1293346000
CY2024Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
12051000
CY2023Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
10895000
CY2024Q1 us-gaap Assets Noncurrent
AssetsNoncurrent
1862199000
CY2023Q4 us-gaap Assets Noncurrent
AssetsNoncurrent
1884238000
CY2024Q1 us-gaap Assets
Assets
2106316000
CY2023Q4 us-gaap Assets
Assets
2109969000
CY2024Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
11938000
CY2023Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
7051000
CY2024Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
100432000
CY2023Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
102478000
CY2024Q1 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
37272000
CY2023Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
35012000
CY2024Q1 us-gaap Business Combination Contingent Consideration Liability Current
BusinessCombinationContingentConsiderationLiabilityCurrent
4454000
CY2023Q4 us-gaap Business Combination Contingent Consideration Liability Current
BusinessCombinationContingentConsiderationLiabilityCurrent
8169000
CY2024Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
49729000
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
46475000
CY2024Q1 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
3639000
CY2023Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
3688000
CY2024Q1 us-gaap Liabilities Current
LiabilitiesCurrent
207464000
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
202873000
CY2024Q1 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
279870000
CY2023Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
280285000
CY2024Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
173255000
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
181357000
CY2024Q1 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
15970000
CY2023Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
15572000
CY2024Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
760000
CY2023Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
952000
CY2024Q1 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
469855000
CY2023Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
478166000
CY2024Q1 us-gaap Liabilities
Liabilities
677319000
CY2023Q4 us-gaap Liabilities
Liabilities
681039000
CY2024Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2024Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
25000000
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
25000000
CY2024Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2024Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2023Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2024Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
800000000
CY2024Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
800000000
CY2024Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
382105000
CY2024Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
382105000
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
378725000
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
378725000
CY2024Q1 us-gaap Common Stock Value
CommonStockValue
3821000
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
3789000
CY2024Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
2204233000
CY2023Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
2183684000
CY2024Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
2886000
CY2023Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
2303000
CY2024Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-781943000
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-760846000
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
1428997000
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
1428930000
CY2024Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
2106316000
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
2109969000
CY2024Q1 us-gaap Revenues
Revenues
300437000
CY2023Q1 us-gaap Revenues
Revenues
252589000
CY2024Q1 us-gaap Other General Expense
OtherGeneralExpense
205711000
CY2023Q1 us-gaap Other General Expense
OtherGeneralExpense
182987000
CY2024Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
88934000
CY2023Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
84626000
CY2024Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
22564000
CY2023Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
19069000
CY2024Q1 us-gaap Operating Expenses
OperatingExpenses
317209000
CY2023Q1 us-gaap Operating Expenses
OperatingExpenses
286682000
CY2024Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-16772000
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-34093000
CY2024Q1 lfst Business Combination Remeasurement Gain Loss On Contingent Consideration
BusinessCombinationRemeasurementGainLossOnContingentConsideration
2015000
CY2023Q1 lfst Business Combination Remeasurement Gain Loss On Contingent Consideration
BusinessCombinationRemeasurementGainLossOnContingentConsideration
1037000
CY2024Q1 lfst Transaction Costs
TransactionCosts
0
CY2023Q1 lfst Transaction Costs
TransactionCosts
86000
CY2024Q1 us-gaap Interest Expense
InterestExpense
5903000
CY2023Q1 us-gaap Interest Expense
InterestExpense
5092000
CY2024Q1 us-gaap Other Expenses
OtherExpenses
74000
CY2023Q1 us-gaap Other Expenses
OtherExpenses
45000
CY2024Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-3962000
CY2023Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-4186000
CY2024Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-20734000
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-38279000
CY2024Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
363000
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-4037000
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-21097000
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-34242000
CY2024Q1 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-0.06
CY2024Q1 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
-0.06
CY2023Q1 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-0.09
CY2023Q1 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
-0.09
CY2024Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
376331000
CY2024Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
376331000
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
360902000
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
360902000
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-21097000
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-34242000
CY2024Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
583000
CY2023Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
-1270000
CY2024Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-20514000
CY2023Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-35512000
CY2023Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1428930000
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-21097000
CY2024Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
583000
CY2024Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
20581000
CY2024Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1428997000
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1518723000
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-34242000
CY2023Q1 lfst Adoption Of Asu Two Zero One Six To One Three
AdoptionOfAsuTwoZeroOneSixToOneThree
-1948000
CY2023Q1 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
-3365000
CY2023Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-1270000
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
27231000
CY2023Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1505129000
CY2024Q1 us-gaap Profit Loss
ProfitLoss
-21097000
CY2023Q1 us-gaap Profit Loss
ProfitLoss
-34242000
CY2024Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
22564000
CY2023Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
19069000
CY2024Q1 lfst Non Cash Operating Lease Costs
NonCashOperatingLeaseCosts
9687000
CY2023Q1 lfst Non Cash Operating Lease Costs
NonCashOperatingLeaseCosts
10113000
CY2024Q1 us-gaap Share Based Compensation
ShareBasedCompensation
20581000
CY2023Q1 us-gaap Share Based Compensation
ShareBasedCompensation
23866000
CY2024Q1 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
424000
CY2023Q1 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
549000
CY2024Q1 lfst Loss Gain On Remeasurement Of Contingent Consideration
LossGainOnRemeasurementOfContingentConsideration
2015000
CY2023Q1 lfst Loss Gain On Remeasurement Of Contingent Consideration
LossGainOnRemeasurementOfContingentConsideration
1037000
CY2024Q1 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
47000
CY2023Q1 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-45000
CY2024Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
50532000
CY2023Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
17138000
CY2024Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-2491000
CY2023Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
4543000
CY2024Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
4981000
CY2023Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-5466000
CY2024Q1 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-2045000
CY2023Q1 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
7663000
CY2024Q1 lfst Increase Decrease In Operating Lease Liabilities
IncreaseDecreaseInOperatingLeaseLiabilities
-9608000
CY2023Q1 lfst Increase Decrease In Operating Lease Liabilities
IncreaseDecreaseInOperatingLeaseLiabilities
-8736000
CY2024Q1 us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
2778000
CY2023Q1 us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
1967000
CY2024Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-21838000
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-7890000
CY2024Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
5104000
CY2024Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
10021000
CY2023Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
8896000
CY2023Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
7729000
CY2024Q1 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
0
CY2023Q1 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
19820000
CY2024Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-5104000
CY2023Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-27549000
CY2024Q1 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
731000
CY2023Q1 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
586000
CY2024Q1 us-gaap Payment For Contingent Consideration Liability Financing Activities
PaymentForContingentConsiderationLiabilityFinancingActivities
1700000
CY2023Q1 us-gaap Payment For Contingent Consideration Liability Financing Activities
PaymentForContingentConsiderationLiabilityFinancingActivities
4302000
CY2024Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-2431000
CY2023Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-4888000
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-29373000
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-40327000
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
78824000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
108621000
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
49451000
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
68294000
CY2024Q1 us-gaap Interest Paid Net
InterestPaidNet
6270000
CY2023Q1 us-gaap Interest Paid Net
InterestPaidNet
5059000
CY2024Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
-252000
CY2023Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
-13000
CY2024Q1 lfst Contingent Consideration Incurred In Acquisitions Of Businesses
ContingentConsiderationIncurredInAcquisitionsOfBusinesses
0
CY2023Q1 lfst Contingent Consideration Incurred In Acquisitions Of Businesses
ContingentConsiderationIncurredInAcquisitionsOfBusinesses
1985000
CY2024Q1 lfst Purchase Of Property Plant And Equipment Included In Accounts Payable And Accrued Expenses
PurchaseOfPropertyPlantAndEquipmentIncludedInAccountsPayableAndAccruedExpenses
3104000
CY2023Q1 lfst Purchase Of Property Plant And Equipment Included In Accounts Payable And Accrued Expenses
PurchaseOfPropertyPlantAndEquipmentIncludedInAccountsPayableAndAccruedExpenses
8297000
CY2024Q1 us-gaap Use Of Estimates
UseOfEstimates
<p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Use of Accounting Estimates</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The preparation of consolidated financial statements in conformity with GAAP requires management to make a number of estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p>
CY2024Q1 lfst Acquisition Of Non Medical Assets
AcquisitionOfNonMedicalAssets
1
CY2024Q1 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
300437000
CY2024Q1 lfst Revenue Recognized As Percentage Of Total Revenue
RevenueRecognizedAsPercentageOfTotalRevenue
1
CY2023Q1 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
252589000
CY2023Q1 lfst Revenue Recognized As Percentage Of Total Revenue
RevenueRecognizedAsPercentageOfTotalRevenue
1
CY2024Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
258621000
CY2023Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
256906000
CY2024Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
76193000
CY2023Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
68684000
CY2024Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
182428000
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
188222000
CY2024Q1 us-gaap Operating Lease Cost
OperatingLeaseCost
13682000
CY2023Q1 us-gaap Operating Lease Cost
OperatingLeaseCost
14308000
CY2024Q1 us-gaap Variable Lease Cost
VariableLeaseCost
0
CY2024Q1 us-gaap Short Term Lease Cost
ShortTermLeaseCost
0
CY2024Q1 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P4Y6M
CY2023Q1 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P4Y7M6D
CY2024Q1 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0722
CY2023Q1 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0711
CY2024Q1 us-gaap Operating Lease Payments
OperatingLeasePayments
16029000
CY2023Q1 us-gaap Operating Lease Payments
OperatingLeasePayments
15339000
CY2024Q1 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
4828000
CY2023Q1 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
6878000
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
47647000
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
63170000
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
55683000
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
42088000
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
29683000
CY2024Q1 lfst Lessee Operating Lease Liability To Be Paid After Year Four
LesseeOperatingLeaseLiabilityToBePaidAfterYearFour
24085000
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
262356000
CY2024Q1 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
39372000
CY2024Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
222984000
CY2024Q1 us-gaap Goodwill
Goodwill
1293346000
CY2023Q4 us-gaap Goodwill
Goodwill
1293346000
CY2024Q1 us-gaap Goodwill Purchase Accounting Adjustments
GoodwillPurchaseAccountingAdjustments
0
CY2024Q1 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
366729000
CY2024Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
158200000
CY2024Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
208529000
CY2023Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
366729000
CY2023Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
145657000
CY2023Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
221072000
CY2024Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
12543000
CY2023Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
10173000
CY2023Q1 lfst Acquisitions Of Outpatient Mental Health Practices
AcquisitionsOfOutpatientMentalHealthPractices
3
CY2024Q1 lfst Acquisitions Of Outpatient Mental Health Practices
AcquisitionsOfOutpatientMentalHealthPractices
0
CY2023Q1 lfst Business Combination Fair Values Of Assets Acquired And Liabilities Assumed Cash
BusinessCombinationFairValuesOfAssetsAcquiredAndLiabilitiesAssumedCash
181000
CY2023Q1 lfst Business Combination Fair Values Of Assets Acquired And Liabilities Assumed Patient Accounts Receivable
BusinessCombinationFairValuesOfAssetsAcquiredAndLiabilitiesAssumedPatientAccountsReceivable
372000
CY2023Q1 lfst Business Combination Fair Values Of Assets Acquired And Liabilities Assumed Prepaid Expenses And Other Current Assets
BusinessCombinationFairValuesOfAssetsAcquiredAndLiabilitiesAssumedPrepaidExpensesAndOtherCurrentAssets
138000
CY2023Q1 lfst Business Combination Fair Values Of Assets Acquired And Liabilities Assumed Property And Equipment
BusinessCombinationFairValuesOfAssetsAcquiredAndLiabilitiesAssumedPropertyAndEquipment
221000
CY2023Q1 lfst Business Combination Fair Values Of Assets Acquired And Liabilities Assumed Right Of Use Assets
BusinessCombinationFairValuesOfAssetsAcquiredAndLiabilitiesAssumedRightOfUseAssets
368000
CY2023Q1 lfst Business Combination Fair Values Of Assets Acquired And Liabilities Assumed Other Noncurrent Assets
BusinessCombinationFairValuesOfAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets
22000
CY2023Q1 lfst Business Combination Fair Values Of Assets Acquired And Liabilities Assumed Intangible Assets
BusinessCombinationFairValuesOfAssetsAcquiredAndLiabilitiesAssumedIntangibleAssets
843000
CY2023Q1 lfst Business Combination Fair Values Of Assets Acquired And Liabilities Assumed Goodwill
BusinessCombinationFairValuesOfAssetsAcquiredAndLiabilitiesAssumedGoodwill
20733000
CY2023Q1 lfst Business Combination Fair Values Of Assets Acquired And Liabilities Assumed Total Assets Acquired
BusinessCombinationFairValuesOfAssetsAcquiredAndLiabilitiesAssumedTotalAssetsAcquired
22878000
CY2023Q1 lfst Business Combination Fair Values Of Assets Acquired And Liabilities Assumed Total Liabilities Assumed
BusinessCombinationFairValuesOfAssetsAcquiredAndLiabilitiesAssumedTotalLiabilitiesAssumed
893000
CY2023Q1 lfst Business Combination Fair Values Of Assets Acquired And Liabilities Assumed Fair Value Of Net Assets
BusinessCombinationFairValuesOfAssetsAcquiredAndLiabilitiesAssumedFairValueOfNetAssets
21985000
CY2023Q1 us-gaap Indefinitelived Intangible Assets Acquired
IndefinitelivedIntangibleAssetsAcquired
843000
CY2024Q1 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
32400000
CY2023Q4 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
67697000
CY2023Q4 us-gaap Business Combination Contingent Consideration Liability
BusinessCombinationContingentConsiderationLiability
8169000
CY2022Q4 us-gaap Business Combination Contingent Consideration Liability
BusinessCombinationContingentConsiderationLiability
17824000
CY2024Q1 lfst Business Combination Additions Related To Acquisitions
BusinessCombinationAdditionsRelatedToAcquisitions
0
CY2023 lfst Business Combination Additions Related To Acquisitions
BusinessCombinationAdditionsRelatedToAcquisitions
1985000
CY2024Q1 lfst Business Combination Payments Of Contingent Consideration
BusinessCombinationPaymentsOfContingentConsideration
-1700000
CY2023 lfst Business Combination Payments Of Contingent Consideration
BusinessCombinationPaymentsOfContingentConsideration
-7668000
CY2024Q1 lfst Business Combination Loss On Remeasurement
BusinessCombinationLossOnRemeasurement
-2015000
CY2023 lfst Business Combination Loss On Remeasurement
BusinessCombinationLossOnRemeasurement
-3972000
CY2023Q4 us-gaap Long Term Debt Fair Value
LongTermDebtFairValue
304955000
CY2024Q1 us-gaap Business Combination Contingent Consideration Liability
BusinessCombinationContingentConsiderationLiability
4454000
CY2023Q4 us-gaap Business Combination Contingent Consideration Liability
BusinessCombinationContingentConsiderationLiability
8169000
CY2024Q1 us-gaap Liabilities Fair Value Disclosure
LiabilitiesFairValueDisclosure
4454000
CY2023Q4 us-gaap Liabilities Fair Value Disclosure
LiabilitiesFairValueDisclosure
8169000
CY2024Q1 us-gaap Long Term Debt
LongTermDebt
288763000
CY2023Q4 us-gaap Long Term Debt
LongTermDebt
289494000
CY2024Q1 us-gaap Long Term Debt Current
LongTermDebtCurrent
2925000
CY2023Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
2925000
CY2024Q1 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
5968000
CY2023Q4 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
6284000
CY2024Q1 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
279870000
CY2023Q4 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
280285000
CY2024Q1 us-gaap Interest Expense
InterestExpense
5903000
CY2023Q1 us-gaap Interest Expense
InterestExpense
5092000
CY2024Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Next Rolling Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextRollingTwelveMonths
2194000
CY2024Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Rolling Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingYearTwo
2925000
CY2024Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Rolling Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingYearThree
2925000
CY2024Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Rolling Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingYearFour
2925000
CY2024Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Rolling Year Five
LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingYearFive
277794000
CY2024Q1 us-gaap Long Term Debt
LongTermDebt
288763000
CY2024Q1 us-gaap Long Term Debt Fair Value
LongTermDebtFairValue
306805000
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Description
ShareBasedCompensationArrangementByShareBasedPaymentAwardDescription
On January 1, 2024, the number of shares of common stock reserved and available for issuance under the 2021 Equity Incentive Plan increased by 18,936 shares.
CY2024Q1 us-gaap Deferred Compensation Arrangement With Individual Allocated Share Based Compensation Expense
DeferredCompensationArrangementWithIndividualAllocatedShareBasedCompensationExpense
20581000
CY2023Q1 us-gaap Deferred Compensation Arrangement With Individual Allocated Share Based Compensation Expense
DeferredCompensationArrangementWithIndividualAllocatedShareBasedCompensationExpense
23866000
CY2024Q1 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
203722000
CY2024Q1 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P2Y1M6D
CY2024Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
363000
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-4037000
CY2024Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.017
CY2023Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.105
CY2024Q1 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2023Q1 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2024Q1 us-gaap Malpractice Insurance Coverage Floor
MalpracticeInsuranceCoverageFloor
3000000
CY2024Q1 us-gaap Malpractice Insurance Annual Coverage Limit
MalpracticeInsuranceAnnualCoverageLimit
8000000
CY2024Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-21097000
CY2023Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-34242000
CY2024Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
376331000
CY2024Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
376331000
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
360902000
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
360902000
CY2024Q1 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-0.06
CY2024Q1 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
-0.06
CY2023Q1 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-0.09
CY2023Q1 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
-0.09
CY2024Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
44978000
CY2023Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
57271000
CY2024Q1 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2024Q1 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2024Q1 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2024Q1 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false
CY2024Q1 lfst Rule10 B51 Arr Modified Flag
Rule10B51ArrModifiedFlag
false
CY2024Q1 lfst Non Rule10 B51 Arr Modified Flag
NonRule10B51ArrModifiedFlag
false

Files In Submission

Name View Source Status
0000950170-24-056989-index-headers.html Edgar Link pending
0000950170-24-056989-index.html Edgar Link pending
0000950170-24-056989.txt Edgar Link pending
0000950170-24-056989-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
lfst-20240331.htm Edgar Link pending
lfst-20240331.xsd Edgar Link pending
lfst-ex31_1.htm Edgar Link pending
lfst-ex31_2.htm Edgar Link pending
lfst-ex32_1.htm Edgar Link pending
lfst-ex32_2.htm Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
lfst-20240331_htm.xml Edgar Link completed
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
FilingSummary.xml Edgar Link unprocessable